PURPOSE: Previous literature provides some evidence that atopic diseases, IgE levels, and inflammatory gene polymorphisms may be associated with risk of glioblastoma. The purpose of this study was to investigate the effects of certain inflammatory gene single nucleotide polymorphisms (SNP) on patient survival. Malignant gliomas are the most common type of primary brain tumor in adults, however, few prognostic factors have been identified. EXPERIMENTAL DESIGN: Using 694 incident adult glioma cases identified between 2001 and 2006 in Harris County, TX, we examined seven SNPs in the interleukin (IL)-4, IL-13, and IL-4 receptor (IL4R) genes. Cox proportional hazards regression was used to examine the association between the SNPs and overall and long-term survival, controlling for age at diagnosis, time between diagnosis and registration, extent of surgical resection, radiation therapy, and chemotherapy. RESULTS: We found that among high-grade glioma cases, IL4R rs1805016 (TT versus GT/GG) was significantly protective against mortality over time [hazard ratios (HR), 0.59; 95% confidence intervals (CI), 0.40-0.88]. The IL4R rs1805016 and rs1805015 TT genotypes were both found to be significantly associated with survival beyond 1 year among patients with high-grade glioma (HR, 0.44; 95% CI, 0.27-0.73 and HR, 0.63; 95% CI, 0.44-0.91, respectively). Furthermore, the IL4R haplotype analysis showed that SNPs in the IL4R gene may be interacting to affect long-term survival among high-grade glioma cases. CONCLUSIONS: These findings indicate that polymorphisms in inflammation pathway genes may play an important role in glioma survival. Further research on the effects of these polymorphisms on glioma prognosis is warranted.
PURPOSE: Previous literature provides some evidence that atopic diseases, IgE levels, and inflammatory gene polymorphisms may be associated with risk of glioblastoma. The purpose of this study was to investigate the effects of certain inflammatory gene single nucleotide polymorphisms (SNP) on patient survival. Malignant gliomas are the most common type of primary brain tumor in adults, however, few prognostic factors have been identified. EXPERIMENTAL DESIGN: Using 694 incident adult glioma cases identified between 2001 and 2006 in Harris County, TX, we examined seven SNPs in the interleukin (IL)-4, IL-13, and IL-4 receptor (IL4R) genes. Cox proportional hazards regression was used to examine the association between the SNPs and overall and long-term survival, controlling for age at diagnosis, time between diagnosis and registration, extent of surgical resection, radiation therapy, and chemotherapy. RESULTS: We found that among high-grade glioma cases, IL4Rrs1805016 (TT versus GT/GG) was significantly protective against mortality over time [hazard ratios (HR), 0.59; 95% confidence intervals (CI), 0.40-0.88]. The IL4Rrs1805016 and rs1805015 TT genotypes were both found to be significantly associated with survival beyond 1 year among patients with high-grade glioma (HR, 0.44; 95% CI, 0.27-0.73 and HR, 0.63; 95% CI, 0.44-0.91, respectively). Furthermore, the IL4R haplotype analysis showed that SNPs in the IL4R gene may be interacting to affect long-term survival among high-grade glioma cases. CONCLUSIONS: These findings indicate that polymorphisms in inflammation pathway genes may play an important role in glioma survival. Further research on the effects of these polymorphisms on glioma prognosis is warranted.
Authors: Frank D Vladich; Susan M Brazille; Debra Stern; Michael L Peck; Raffaella Ghittoni; Donata Vercelli Journal: J Clin Invest Date: 2005-03 Impact factor: 14.808
Authors: H Mitsuyasu; K Izuhara; X Q Mao; P S Gao; Y Arinobu; T Enomoto; M Kawai; S Sasaki; Y Dake; N Hamasaki; T Shirakawa; J M Hopkin Journal: Nat Genet Date: 1998-06 Impact factor: 38.330
Authors: Judith Schwartzbaum; Anders Ahlbom; Beatrice Malmer; Stefan Lönn; Anthony J Brookes; Hani Doss; Waldemar Debinski; Roger Henriksson; Maria Feychting Journal: Cancer Res Date: 2005-07-15 Impact factor: 12.701
Authors: Ioannis Moissidis; Birjis Chinoy; Krishna Yanamandra; Dawn Napper; Theodore Thurmon; Joseph Bocchini; Sami L Bahna Journal: Genet Med Date: 2005 Jul-Aug Impact factor: 8.822
Authors: Timothy D Howard; Gerard H Koppelman; Jianfeng Xu; Siqun L Zheng; Dirkje S Postma; Deborah A Meyers; Eugene R Bleecker Journal: Am J Hum Genet Date: 2001-11-14 Impact factor: 11.025
Authors: M Fatih Okcu; Mano Selvan; Li-E Wang; Linda Stout; Rodrigo Erana; Gladstone Airewele; Phyllis Adatto; Kenneth Hess; Francis Ali-Osman; Morris Groves; Alfred W K Yung; Victor A Levin; Qingyi Wei; Melissa Bondy Journal: Clin Cancer Res Date: 2004-04-15 Impact factor: 12.531
Authors: Joseph L Wiemels; John K Wiencke; Karl T Kelsey; Michelle Moghadassi; Terri Rice; Kevin Y Urayama; Rei Miike; Margaret Wrensch Journal: Cancer Epidemiol Biomarkers Prev Date: 2007-06 Impact factor: 4.254
Authors: Bryan A Bassig; Peter D Inskip; Laurie Burdette; William R Shapiro; Robert G Selker; Howard A Fine; Jay S Loeffler; Peter M Black; Robert Dubrow; Alina V Brenner Journal: J Neuroimmunol Date: 2010-12-30 Impact factor: 3.478
Authors: Mitsugu Fujita; Michael E Scheurer; Stacy A Decker; Heather A McDonald; Gary Kohanbash; Edward R Kastenhuber; Hisashi Kato; Melissa L Bondy; John R Ohlfest; Hideho Okada Journal: Clin Cancer Res Date: 2010-05-14 Impact factor: 12.531
Authors: Daniel H Lachance; Ping Yang; Derek R Johnson; Paul A Decker; Thomas M Kollmeyer; Lucie S McCoy; Terri Rice; Yuanyuan Xiao; Francis Ali-Osman; Frances Wang; Shawn M Stoddard; Debra J Sprau; Matthew L Kosel; John K Wiencke; Joseph L Wiemels; Joseph S Patoka; Faith Davis; Bridget McCarthy; Amanda L Rynearson; Joel B Worra; Brooke L Fridley; Brian Patrick O'Neill; Jan C Buckner; Dora Il'yasova; Robert B Jenkins; Margaret R Wrensch Journal: Am J Epidemiol Date: 2011-07-08 Impact factor: 4.897
Authors: Danielle M Backes; Afshan Siddiq; David G Cox; Federico C F Calboli; J Michael Gaziano; Jing Ma; Meir Stampfer; David J Hunter; Carlos A Camargo; Dominique S Michaud Journal: J Neurooncol Date: 2013-03-25 Impact factor: 4.130
Authors: Judith A Schwartzbaum; Yuanyuan Xiao; Yanhong Liu; Spyros Tsavachidis; Mitchel S Berger; Melissa L Bondy; Jeffrey S Chang; Susan M Chang; Paul A Decker; Bo Ding; Sarah J Hepworth; Richard S Houlston; Fay J Hosking; Robert B Jenkins; Matthew L Kosel; Lucie S McCoy; Patricia A McKinney; Kenneth Muir; Joe S Patoka; Michael Prados; Terri Rice; Lindsay B Robertson; Minouk J Schoemaker; Sanjay Shete; Anthony J Swerdlow; Joe L Wiemels; John K Wiencke; Ping Yang; Margaret R Wrensch Journal: Carcinogenesis Date: 2010-07-28 Impact factor: 4.944